Hepatocellular carcinoma: Summary and recommendations

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  Hoofnagle, Jay H ^a,b  

^a Natl Inst Diabet Digest K   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ANTIVIRUS AGENT; HERBACEOUS AGENT; PEGINTERFERON; RETINOID;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; CONFERENCE PAPER; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 7044270974     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.047     Document Type: Conference Paper

References (44)

1. F.X. Bosch, J. Ribes, J. Borras Epidemiology of primary liver cancer Semin Liver Dis 19 1999 271 285
2. M.W. Russo, J.T. Wei, M.T. Thiny, L.M. Gangarosa, A. Brown, Y. Ringel, N.J. Shaheen, R.S. Sandler Digestive and liver disease statistics, 2004 Gastroenterology 126 2004 1448 1453
3. H.B. El Serag, J.A. Davila, N.J. Petersen, K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States an update Ann Intern Med 139 2003 817 823
4. R.T. Greenlee, M.B. Hill-Harmon, Y. Murray, M. Thun Cancer statistics, 2001 CA Cancer J Clin 51 2001 15 36
5. K. Okuda, I. Fujimoto, A. Hanai, Y. Urano Changing incidence of hepatocellular carcinoma in Japan Cancer Res 47 1987 4967 4972
6. K. Kiyosawa, T. Umemura, T. Ichigo, A. Matsumoto, K. Yoshizawa, E. Tanaka Hepatocellular carcinoma Recent trends in Japan Gastroenterology 127 2004 S17 S26
7. C. La Vecchia, F. Lucchini, S. Franceschi, E. Negri, F. Levi Trends in mortality from primary liver cancer in Europe Eur J Cancer 36 2000 909 915
8. S. Deuffic, T. Poynard, A.J. Valleron Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe J Viral Hepat 6 1999 411 413
9. H.B. El Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 2002 S74 S83
10. T.J. Liang, B. Rehermann, L.B. Seeff, J.H. Hoofnagle Pathogenesis, natural history, treatment, and prevention of hepatitis C Ann Intern Med 132 2000 296 305
11. G. Fattovich, G. Giustina, F. Degos, F. Tremolada, G. Diodati, P. Almasio, F. Nevens, A. Solinas, D. Mura, J.T. Brouwer, H. Thomas, C. Njapoum, C. Casarin, P. Bonetti, P. Fuschi, J. Basho, A. Tocco, A. Bhalla, R. Galassini, F. Noventa, S.W. Schalm, G. Realdi Morbidity and mortality in compensated cirrhosis C a retrospective follow-up study of 384 patients Gastroenterology 112 1997 463 472
12. A.M. Di Bisceglie, A.C. Lyra, M. Schwartz, R.K. Reddy, P. Martin, G. Gores, A.S. Lok, K.B. Hussain, R. Gish, D.H. Van Thiel, Z. Younossi, M. Tong, T. Hassanein, L. Balart, J. Fleckenstein, S. Flamm, A. Blei, A.S. Befeler Hepatitis C related hepatocellular carcinoma in the United States influence of ethnic status Am J Gastroenterol 98 2003 2060 2063
13. F. Donato, A. Tagger, R. Chiesa, M.L. Ribero, V. Tomasoni, M. Fasola, U. Gelatti, G. Portera, P. Boffetta, G. Nardi Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma a case-control study Hepatology 26 1997 579 584
14. H.B. El Serag, C. Mason, C. Key Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States Hepatology 33 2001 62 65
15. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto, M. Ammatuna, A. Morabito, L. Gennari Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
16. R.H. Wiesner, R.B. Freeman, D.C. Mulligan Liver transplant for hepatocellular cancer. The impact of the MELD allocation policy Gastroenterology 127 2004 S261 S268
17. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong, D.C. Liang, W.Y. Shau, D.S. Chen Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children N Engl J Med 336 1997 1855 1859
18. Center for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR Recomm Rep 47 1998 1 39 (RR-19)
19. A.S.F. Lok Prevention of hepatitis B virus-related hepatocellular carcinoma Gastroenterology 127 2004 S303 S309
20. E.J. Heathcote Prevention of hepatitis C virus-related hepatocellular carcinoma Gastroenterology 127 2004 S294 S302
21. Y.F. Liaw, J.Y.J. Sung, C.W. Chow, K. Shue, O. Keene, F. Farrell Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B a prospective double-blind placebo-controlled clinical trial (abstr) Hepatology 38 2003 262 263
22. S. Nishiguchi, T. Kuroki, S. Nakatani, H. Morimoto, T. Takeda, S. Nakajima, S. Shimoi, S. Seki, K. Kobayashi, S. Otani Randomised trial of effects of interferon α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1995 1051 1055
23. H. Yoshida, Y. Shiratori, M. Moriyama, Y. Arakawa, T. Ide, M. Sata, I. Osami, M. Yano, M. Tanaka, S. Fujiyama, S. Nishiguchi, T. Kuroki, F. Imazeki, O. Yokosuka, S. Kinoyama, G. Yamada, M. Omata Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy Ann Intern Med 131 1999 174 181
24. M. Omata, R. Tateishi, H. Yoshida, S. Shiina Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods ethanol injection therapy and radiofrequency ablation Gastroenterology 2004 127 2004 S159 S166
25. G.V. Papatheodoridis, V.C. Papadimitropoulos, S.J. Hadziyannis Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis a meta-analysis Aliment Pharmacol Ther 15 2001 689 698
26. T.W. Kensler, P.A. Egner, J.-B. Wang, Y.R. Zhu, B.-C. Zhang, P.-X. Lu, J.-G. Chen, G.-S. Qian, S.-Y. Kuang, P.E. Jackson, S.J. Gange, L.P. Jacobson, A. Munoz, J.D. Groopman Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas Gastroenterology 127 2004 S310 S318
27. Y. Muto, H. Moriwaki, M. Ninomiya, S. Adachi, A. Saito, K.T. Takasaki, T. Tanaka, K. Tsurumi, M. Okuno, E. Tomita, T. Nakamura, T. Kojima Hepatoma Prevention Study Group Prevention of second tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma N Engl J Med 334 1996 1561 1567
28. M.L. Shiffman, A.M. Di Bisceglie, K.L. Lindsay, C. Morishima, E.C. Wright, G.T. Everson, A.S. Lok, T.R. Morgan, H.L. Bonkovsky, W.M. Lee, J.L. Dienstag, M.G. Ghany, Z.D. Goodman, J.E. Everhart Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment Gastroenterology 126 2004 1015 1023
29. A.M. Di Bisceglie Issues in screening and surveillance for hepatocellular carcinoma Gastroenterology 127 2004 S104 S107
30. B. Daniele, A. Bencivenga, A.S. Megna, V. Tinessa Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma Gastroenterology 127 2004 S108 S112
31. J.A. Marrero, A.S.F. Lok Newer markers for hepatocellular carcinoma Gastroenterology 127 2004 S113 S119
32. J.-S. Lee, S.S. Thorgeirsson Genome-scale profiling of gene expression in hepatocellular carcinoma classification, survival prediction, and identification of therapeutic targets Gastroenterology 127 2004 S51 S55
33. A.M. Gharib, D. Thomasson, K.C.P. Li Molecular imaging of hepatocellular carcinoma Gastroenterology 127 2004 S153 S158
34. T.-J. Song, E.W.K. Ip, Y. Fong Hepatocellular carcinoma current surgical management Gastroenterology 127 2004 S248 S260
35. J. Bruix, M. Sala, J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 2004 S179 S188
36. H.W. Head, G.D. Dodd III Thermal ablation for hepatocellular carcinoma Gastroenterology 127 2004 S167 S178
37. F.A. Jolesz, K. Hynynen, N. McDannold, D. Freundlich, D. Kopelman Noninvasive thermal ablation of hepatocellular carcinoma using magnetic resonance imaging-guided focused ultrasound Gastroenterology 127 2004 S242 S247
38. D.A. Bush, D.J. Hillebrand, J.M. Slater, J.D. Slater High-dose proton beam radiotherapy in hepatocellular carcinoma preliminary results Gastroenterology 127 2004 S189 S194
39. J.F.H. Geschwind, R. Salem, B.I. Carr, M.C. Soulen, K.G. Thurston, K.A. Goin, G.M. Van Buskirk, C.A. Roberts, J.E. Goin Yttrium-90 microspheres for the treatment of hepatocellular carcinoma in selected patients Gastroenterology 127 2004 S194 S205
40. J.M. Llovet, J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival Hepatology 37 2003 429 442
41. C.C. Harris Structure and function of the p53 tumor suppressor gene clues for rational cancer therapeutic strategies J Natl Cancer Inst 88 1996 1442 1455
42. J.M. Goldman, J.V. Melo Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia (editorial) N Engl J Med 344 2001 1084 1085
43. L.H. Butterfield Immunotherapeutic strategies for hepatocellular carcinoma Gastroenterology 127 2004 S232 S241
44. L. Mohr, A. Yeung, C. Aloman, D. Wittrup, J.R. Wands Antibody directed therapy of human hepatocellular carcinoma Gastroenterology 127 2004 S225 S231